CAS 1044758-60-2
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Etrolizumab
CAS :MEDI-578 is a CHO-expressed humanized monoclonal antibody targeting NGF/bNGF for the study of neurological and immune system disorders.Degré de pureté :98.9% (SDS-PAGE); 96.6% (SEC-HPLC) - 98.9% (SDS-PAGE); 96.6% (SEC-HPLC)Couleur et forme :Liquid
